首页 | 本学科首页   官方微博 | 高级检索  
     

胺碘酮对特发性房颤心房重构逆转作用观察
引用本文:张义飞,柳荫,王建榜,张录兴,郑强荪. 胺碘酮对特发性房颤心房重构逆转作用观察[J]. 心脏杂志, 2002, 14(3): 229-231. DOI: 10.13191/j.chj.2002.03.51.zhangyf.021
作者姓名:张义飞  柳荫  王建榜  张录兴  郑强荪
作者单位:1. 第四军医大学唐都医院心内科
2. 陕西省纺织职工医院,陕西,西安,710038
摘    要:目的 :探讨胺碘酮对特发性房颤的治疗及对逆转心房心肌重构的作用。方法 :选择 1998- 0 6~ 2 0 0 0 - 0 7住院的特发性房颤患者 (除外房颤持续时间小于 6月和阵发性房颤间隔小于 1月 ,每次持续时间少于 48h者 ) 94例。随机分为胺碘酮治疗组 32例 ,普罗帕酮治疗组 32例及安慰剂组 30例。治疗前后行心电图、心脏超声、肝、肾功及甲状腺功能检查。出院后嘱患者 1,3,6 ,12月复查上述项目 1次。结果 :胺碘酮与普罗帕酮治疗组 ,均可使特发性房颤复律 ,但胺碘酮组较普罗帕酮组复律时间稍长 (约 1周 ) ,维持窦性心律的作用中 ,胺碘酮优于普罗帕酮组 ,12月后转复成功率分别为 81%和 5 6 % ,与安慰剂组自动复律 2 0 % (6 / 30 )比较有显著差异 (P<0 .0 1)。随访 1,3,6 ,12月胺碘酮组左心房直径缩小 ,左心室舒张早期经二尖瓣血流的最高值 (E峰值 )和左心房收缩时经二尖瓣血流的最大值 (A峰值 )、E/ A增大。1,3,6 ,12月间比较有显著性差异 (P<0 .0 1) ,普罗帕酮组上述指标有所改善 ,但差异不显著 (P>0 .0 5 ) ,安慰剂组则无变化。结论 :胺碘酮对特发性房颤复律及对逆转心房心肌重构安全有效

关 键 词:胺碘酮   心房颤动   重构逆转
文章编号:1009-7236(2002)03-0229-03
修稿时间:2002-01-14

Effect of Amiodarone on reversion of atrial remodeling in patients with idiopathic atrial fibrillation
ZHANG Yi-fei ,LIU Yin ,WANG Jian-bang ,ZHANG Lu-xing ,ZHENG Qiang-sun. Effect of Amiodarone on reversion of atrial remodeling in patients with idiopathic atrial fibrillation[J]. Chinese Heart Journal, 2002, 14(3): 229-231. DOI: 10.13191/j.chj.2002.03.51.zhangyf.021
Authors:ZHANG Yi-fei   LIU Yin   WANG Jian-bang   ZHANG Lu-xing   ZHENG Qiang-sun
Affiliation:ZHANG Yi-fei 1,LIU Yin 1,WANG Jian-bang 2,ZHANG Lu-xing 1,ZHENG Qiang-sun 1
Abstract:AIM: To observe the effect of amiodarone on reversion of atrial remodeling in enlarged atria of patients with idiopathic atrial fibrillation. METHODS: 94 continuous inpatients with idiopathic atrial fibrillation who were hospitalized from June 1998 to July 2000 were randomized into amiodarone group (n=32), propafenone group (n=32) and control group(n=30). Electrocardiogram (ECG), ultrasonography of heart, liver function, renal function and thyroid function were measured at before treatment, and 1, 3, 6, 12 month after treatment period respectively. RESULTS: Amiodarone and propafenone converted all of atrial fibrillation to sinus rhythm immediately after treatment, with a longer treatment period in amiodarone group (about 1 week) than that of propafenone group. At 12 month after treatment period, there was a significant higher sinus rhythm ratio in amiodarone ( 81% vs 20%, P<0.01) and propafenone group (56% vs 20%, P<0.01) than control group. There were a smaller left atrial diameter, a higher peak value of blood flow via mitral valve at early left ventricular diastole period (E value), a higher peak value of blood flow via mitral valve at left atrial diastole period (A value) and a higher E/A ratio at 1, 3, 6 and 12 month after treatment period than before treatment respectively in amiodarone group, with a significant difference between any two of different time point (P<0.01). CONCLUSION: There was a significant effect of amiodarone on reversion of atrial remodeling in enlarged atria of patients with idiopathic atrial fibrillation.
Keywords:amiodarone  atrial fibrillation  reversion of atrial remodeling
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《心脏杂志》浏览原始摘要信息
点击此处可从《心脏杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号